Closed System Drug Transfer Device (CSTD) Market Research Report Information By Type (Barrier Type and Filtration Type) by Closing Mechanism (Push to Turn System, Color-to-Color Alignment System, Leur Lock Systems, and Others), by Component (Vial Access D

Closed System Drug Transfer Device (CSTD) Market Research Report Information By Type (Barrier Type and Filtration Type) by Closing Mechanism (Push to Turn System, Color-to-Color Alignment System, Leur Lock Systems, and Others), by Component (Vial Access Devices, Syringe Safety Devices, Bag/Infusion Set Devices, and Others), by Technology (Compartmentalize Devices, Diaphragm-based Devices, and Air Filtration Devices) by End User (Hospitals & Clinics, Specialty Centers, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2032

Market Synopsis

The industry for closed system drug transfer devices (CSTDs) is expected to develop at a compound annual growth rate (CAGR) of 17.51% between 2024 and 2032, from USD 0.99 billion in 2024 to USD 3.63 billion. The need for CSTDs is rising due to the growing usage of hazardous medications, oncology treatments, and home healthcare, and the market is expanding due to the healthcare industry's strict regulatory requirements.

The increasing use of dangerous pharmaceuticals in the medical field is one of the main factors that is dramatically influencing the worldwide healthcare environment. In general, approximately 8 million US healthcare workers—including pharmacists, nurses, doctors, operating room personnel, environmental services personnel, workers in research laboratories, veterinary care providers, and shipping and receiving personnel—may be exposed to hazardous drugs, according to the Centers for Disease Control and Prevention.

Moreover, the strict regulatory environment established by healthcare authorities, including the FDA in the United States, has required the mandatory use of CSTDs during the complex procedures involved in the manufacturing and delivery of hazardous drugs. The importance of CSTDs in reducing exposure risks is highlighted by this regulatory framework, which further solidifies their position in the market as an essential part of contemporary healthcare practice. Furthermore, the increased awareness of safety measures together with the rising incidence of chronic illnesses expedites the incorporation of CSTDs into the standard operating procedures of healthcare facilities across the globe.

Insights on Market Segments

Barrier type and filter type are included in the type-based market segmentation of Closed System Drug Transfer Devices (CSTD).

The market is divided into push-to-turn, color-to-color alignment, leur lock, and other categories based on closing mechanisms.

The market is segmented based on components, including bag/infusion set devices, syringe safety devices, and vial access devices.

The market is divided into three categories depending on technology: air filtration devices, diaphragm-based devices, and compartmentalize devices.

Hospitals & clinics, specialty centers, and other end users are included in the segmentation of the Closed System Drug Transfer Device (CSTD) market based on end user.

Localized Perspectives

In 2022, the closed system drug transfer device (CSTD) market in North America held the greatest market share. This is because the North American region has a robust infrastructure for research and development as well as a rising prevalence of cancer patients.

Europe has the second-largest market share for closed system drug transfer devices (CSTDs) because of the region's well-established research and development infrastructure, highly developed healthcare sector, and easy access to CSTD products.

From 2024 to 2032, the closed system drug transfer device (CSTD) market in Asia-Pacific is anticipated to expand at a substantial rate. This is because there are more and more niche market players vying for market share, which is contributing to the rise in the number of new vendors entering the drug-device system.

Principal Players

Becton, Dickinson and Company (US), BRAUN SE (Germany), Epic Medical (Singapore), JMS Co. Ltd (Japan), Equashield (US), ICU Medical, Inc. (US), Yukon Medical (US), Caragen Ltd (Ireland), and Corvida Medical (US) are some of the major players in the Closed System Drug Transfer Device (CSTD) market.